Treatment-Related Adverse Events of PD-1 and PD-L1 Inhibitors in Clinical Trials: A Systematic Review and Meta-analysis

IMPORTANCE: Programmed cell death (PD-1) and programmed cell death ligand 1 (PD-L1) inhibitors have been increasingly used in cancer therapy. Understanding the treatment-related adverse events of these drugs is critical for clinical practice. OBJECTIVE: To evaluate the incidences of treatment-relate...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:JAMA Oncol
Main Authors: Wang, Yucai, Zhou, Shouhao, Yang, Fang, Qi, Xinyue, Wang, Xin, Guan, Xiaoxiang, Shen, Chan, Duma, Narjust, Vera Aguilera, Jesus, Chintakuntlawar, Ashish, Price, Katharine A., Molina, Julian R., Pagliaro, Lance C., Halfdanarson, Thorvardur R., Grothey, Axel, Markovic, Svetomir N., Nowakowski, Grzegorz S., Ansell, Stephen M., Wang, Michael L.
Formato: Artigo
Idioma:Inglês
Publicado em: American Medical Association 2019
Assuntos:
Original Investigation
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6487913/
https://ncbi.nlm.nih.gov/pubmed/31021376
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaoncol.2019.0393
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados